News publication
Everything we hold that vexev.com published.
Every article we hold from vexev.com.
Australian medical robotics firm Vexev has raised A$8.6 million to pursue FDA clearance and US commercialisation of its VxWave robotic ultrasound platform, with backing from existing and new investors.
Also Startup Daily·This Week in Australian Startups·SmartCompany
Sydney-based medical robotics maker Vexev announced a $6 million raise to pursue FDA clearance and US commercialisation of its VxWave robotic vascular ultrasound platform, with existing and new investors participating.
Under Ten13 ·leads this story in the feed
Deals recorded from vexev.com's coverage. A round is listed once, however many of their articles mention it.
Companies named in vexev.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| American Society of Nephrology | 2 | |
| U.S. Renal Care | 2 | |
| University of Alabama at Birmingham | 2 | |
| Vexev | AI-powered robotic ultrasound for vascular imaging | 2 |
Investors named in vexev.com's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Alumni Ventures | 2 | |
| Bioshore Ventures | 2 | |
| Blackbird Ventures | 2 | |
| Horizon | 2 | |
| Neotribe Ventures | 2 | |
| Startmate | Early-stage investment and mentorship for founders | 2 |
| Ten13 | 2 | |
| TreeArc | 2 |